1Maxfield E K,Cameron N E,Cotter M A. Effects of diabetes on reactivity of sciatic vasa nervorun in rats [J]. J Diabetes Compl,1997,11(1):472.
2Thrailkiu K M,Ouattrin T,Baker L,et al. Cotherapy with recombinantinsulin 2 like growth factor 1 and insulin improves glycemic control in type 1 diabetics [J]. Diabetes Care, 1999,22(4) : 585-593.
3Janssen J A,Lambert S. Circulating IGF21 and its protective role in the pathogenesis of diabetic angiopathy [J ]. Clin Endocrinol, 2000,52 ( 1 ) : 129.
4Morise T,Takeuchi Y,Kawano M,et al. Increased plasma levels of immunoreactive endothelin and von willebrand factor in NIDDM patients [J]. Diabetes Care, 1995,18(1):87-89.
5Stephenson J M,Fuller J H. The eurodiab iddm complication study group blood pressure ,retinopathy and urinary albumin excretion in iddm[J]. Diabetologia, 1995,38:599-603.
6Kunz M ,Merges C. Vascular endothelial growth factor and vascular permrahility changes in human diabetic retinopathy [J]. Invest Ophthalmol Vis Sci, 1997,38:2 729-2 741.
7Amin R H,Frand R N. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retonopathy[J]. Invest Ophthalmol Vis Sci, 1997, 38:36-37.
8Adamid A P,Miller J W. BERNAI. M T,et al. Increased vascular endothelial grwth factor levels in the vitreous of eyes with proliferative diabetic retinopathy[J]. Am J Opathalmol, 1994, 118: 445- 450.
9Wada T,Furuichi K,Sakai N,et al. Up regulation of monocyte chemoattractant protein21 in tubulointerstitial le2 sions of human diabetic nephropathy[J]. Kidney Int,2000,58:1 492 1 499.
10Banba N,Nakamura T,Matsumura M ,et al. Possible relationship of monocyte chemoattractant protein with diabetic nephropathy[J]. Kidney Int, 2000, 58: 684-690.
